Marina Kleanthous holds a B.S. degree in biology from the University of Thessaloniki, Thessalonica, Greece, in 1981 and a Ph.D. degree in neurochemistry from the University of Athens, Athens, Greece, in 1989. She specialized in molecular biology at the IMBB of Crete, the Medical Collage of Georgia, Augusta, GA, USA and the Division of Medical Genetics at the University of Washington, Seattle, Wash, USA. She is currently Director of the Molecular Biology and Thalassaemia Department at The Cyprus Institute of Neurology and Genetics. She has extensive experience in the diagnosis of different forms of thalassaemia, other haemoglobinopathies, other rare hereditary disorders, prenatal diagnosis and preimplantation genetic diagnosis (PGD) for thalassaemia, and other diseases. Her research interests involve the identification of new HbF inducing agents for thalassaemia treatment, gene therapy for thalassaemia, and the development of noninvasive prenatal diagnosis (NIPD) for thalassaemia.
Biography Updated on 14 May 2012